skip to main content

Safest TKI Vascular Risk — RACP Adult Medicine MCQ

Instant feedback + full explanation. One question, done properly.

EasyHaematologySafest TKI Vascular RiskRACP Adult Medicine

A 65-year-old man with CML on nilotinib develops PAD. Which alternative TKI has the lowest vascular risk?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: CImatinib

Imatinib has the lowest vascular toxicity of all TKIs. Nilotinib and ponatinib have the highest. Switch to imatinib if significant PAD.

Reference: eTG – 2025 – Haematology; ELN – 2020